The acquired company is a leader in the field of delivery systems and medical devices

Effective October 7th, the P&R SpA Group has completed the acquisition of the Italian based…

September 17 - 19, 2014

As a company dedicated to the mission of advancing innovation in joint healthcare, Fidia supports the Course with an Educational Grant.

The course aims to provide a platform for Trainees and Specialists interested in musculoskeletal…

AEONSurgical’s team will sell Hyalgan® alongside Fidia’s direct sales force.

PARSIPPANY, N.J., & SAN ANTONIO, TX; September 15, 2014, -- Fidia Pharma USA Inc., a wholly-owned…

September 7 through 14, 2014

Fidia farmaceutici is ‘superior sponsor’ of the 5th edition of one of the world’s most fascinating…

Fidia Pharma USA’s national sales force coverage strengthens Fidia’s presence in the US market and constitutes a strong platform for further expansion

PARSIPPANY, N.J. & ABANO TERME, Italy July 07, 2014 -- Fidia Pharma USA Inc., a wholly-owned…

Learn more about our consumer products for joint healthcare.

Fidia farmaceutici proposes a new product website dedicated to its supplement line, that helps…

With a booth and a Satellite Symposium, a further confirmation of the Company's commitment in joint healthcare

FIDIA Farmaceutici S.p.A. will participate in the forthcoming Annual Congress of the European League…

An opportunity to showcase FIDIA's unique capabilities

FIDIA Farmaceutici S.p.A., the Italian pharmaceutical company leader in hyaluronic acid (HY) - based…

An additional step in the Company's internationalization plan

The Italian multinational company Fidia Farmaceutici, a global leader in R&D and production of…


Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine